115 related articles for article (PubMed ID: 6451288)
1. Cholestatic jaundice associated with chlorozotocin.
Belt RJ; McGregor D; Haas CD; Bhatia PS
Cancer Treat Rep; 1980; 64(12):1235-9. PubMed ID: 6451288
[TBL] [Abstract][Full Text] [Related]
2. Phase II evaluation of chlorozotocin in patients with non-small cell carcinoma of the lung.
Casper ES; Gralla RJ
Cancer Treat Rep; 1979 Apr; 63(4):549-50. PubMed ID: 156068
[No Abstract] [Full Text] [Related]
3. Phase II evaluation of chlorozotocin in advanced bronchogenic carcinoma.
Creagan ET; Eagan RT; Fleming TR; Frytak S; Kvols LK; Ingle JN
Cancer Treat Rep; 1979; 63(11-12):2105-6. PubMed ID: 230898
[No Abstract] [Full Text] [Related]
4. Phase II study of chlorozotocin in the treatment of advanced colorectal cancer.
Lawton JO; Giles GR; Hall J; MacAdam A; Hall R; Matheson T; Bird G
Cancer Treat Rep; 1981; 65(1-2):13-15. PubMed ID: 6452945
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary disease as a complication of chlorozotocin chemotherapy.
Ahlgren JD; Smith FP; Kerwin DM; Sikic BI; Weiner JH; Schein PS
Cancer Treat Rep; 1981; 65(3-4):223-9. PubMed ID: 6453644
[TBL] [Abstract][Full Text] [Related]
6. Phase II evaluation of AMSA in patients with metastatic lung cancer.
Nichols WC; Eagan RT; Frytak S; Ingle JN; Creagan ET; Kvols LK
Cancer Treat Rep; 1980; 64(12):1383-5. PubMed ID: 6894104
[TBL] [Abstract][Full Text] [Related]
7. High-dose chlorozotocin in lung cancer: a Southwest Oncology Group Phase II Study.
Haas CD; Stephens RL; Bukowski RM; Stuckey WJ; McCracken JD; Gagliano RG; Lehane DE; Pugh RP
Cancer Treat Rep; 1983; 67(7-8):705-7. PubMed ID: 6223694
[No Abstract] [Full Text] [Related]
8. Phase II study of chlorozotocin in non-small cell carcinoma of the lung.
Cornell CJ; Hoth D; Pajak TF
Cancer Treat Rep; 1981; 65(7-8):734-5. PubMed ID: 6454488
[No Abstract] [Full Text] [Related]
9. Sildenafil-induced severe cholestatic hepatotoxicity.
Enomoto M; Sakaguchi H; Ominami M; Iwai S; Morikawa H; Tamori A; Kawada N
Am J Gastroenterol; 2009 Jan; 104(1):254-5. PubMed ID: 19098889
[No Abstract] [Full Text] [Related]
10. Phase I evaluation of chlorozotocin: single dose every six weeks.
Taylor S; Belt RJ; Haas CD; Stephens RL; Hoogstraten B
Cancer; 1980 Dec; 46(11):2365-8. PubMed ID: 6449279
[TBL] [Abstract][Full Text] [Related]
11. Chlorozotocin (DCNU)--induced pulmonary toxicity.
Sordillo EM; Sordillo PP; Stover D; Magill GB
Cancer Clin Trials; 1981; 4(4):397-9. PubMed ID: 6459189
[TBL] [Abstract][Full Text] [Related]
12. [Results of a new trial of prolonged polychemotherapy of inoperable broncho-pulmonary cancers (apropos of 173 cases)].
Decroix G; Sors C; Feldman A; Fournier M
Bull Mem Soc Med Hop Paris; 1968; 119(2):169-78. PubMed ID: 5670365
[No Abstract] [Full Text] [Related]
13. Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
Osterlind K; Hørbov S; Dombernowsky P; Rørth M; Hansen HH
Cancer Treat Rep; 1982 Feb; 66(2):305-9. PubMed ID: 7055816
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of VP-16-213 in non-small-cell lung cancer.
Itri LM; Gralla RJ; Chapman RA; Kelsen DP; Casper ES; Golbey RB
Am J Clin Oncol; 1982 Feb; 5(1):45-7. PubMed ID: 7081137
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group.
Mouridsen HT; Bramwell VH; Lacave J; Metz R; Vendrik C; Hild J; McCreanney J; Sylvester R
Cancer Treat Rep; 1981; 65(5-6):509-11. PubMed ID: 6453646
[TBL] [Abstract][Full Text] [Related]
16. Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
Luedke SL; Luedke DW; Petruska P; Broun GO; Reed G; Leavitt J
Cancer Treat Rep; 1982 Jun; 66(6):1409-11. PubMed ID: 7083243
[TBL] [Abstract][Full Text] [Related]
17. Phase II evaluation of chlorozotocin in patients with renal cell carcinoma.
Gralla RJ; Yagoda A
Cancer Treat Rep; 1979 Jun; 63(6):1007-8. PubMed ID: 157222
[No Abstract] [Full Text] [Related]
18. [Nitrullin -- a new original Russian drug of the nitrosomethylurea group].
Gorbunova VA; Orel NF; Semina OV; Besova NS; Kadagidze ZG
Vopr Onkol; 2001; 47(6):680-3. PubMed ID: 11826488
[TBL] [Abstract][Full Text] [Related]
19. Cholestatic jaundice induced by flurazepam hydrochloride.
Reynolds R; Lloyd DA; Slinger RP
Can Med Assoc J; 1981 Apr; 124(7):893-4. PubMed ID: 7214289
[No Abstract] [Full Text] [Related]
20. Paraneoplastic cholestasis associated with prostate carcinoma.
Koruk M; Büyükberber M; Savaş C; Kadayifçi A
Turk J Gastroenterol; 2004 Mar; 15(1):53-5. PubMed ID: 15264123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
